Skip to main content

Want a detailed portfolio tracker?

Adaptimmune Therapeutics plc American Depositary Shares (ADAP) P/E (2015 - 2025)

Adaptimmune Therapeutics plc American Depositary Shares (ADAP) P/E from Jun 30, 2015 to Oct 27, 2025. The TTM Adaptimmune Therapeutics plc American Depositary Shares (ADAP) P/E is -0.50. You can export chart.

P/E

Annual P/E change of Adaptimmune Therapeutics plc American Depositary Shares (ADAP)

YearP/EChange
2025-0.50-95.45%
2024-10.92+13.03%
2023-9.66+21.42%
2022-7.96-64.10%
2021-22.16-36.10%
2020-34.68+529.65%
2019-5.51-83.86%
2018-34.12-36.19%
2017-53.47+100.61%
2016-26.65-85.47%
2015-183.46N/A

Comparison Adaptimmune Therapeutics plc American Depositary Shares (ADAP) P/E with competitors

Adaptimmune Therapeutics plc American Depositary Shares (ADAP) P/E is -0.50.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.34%
NBYStablecoin Development Corp0.00-100.87%
ENLVEnlivex Ltd0.07-115.06%
FGENFibroGen Inc0.24-148.31%
CHRSCoherus Biosciences Inc0.85-270.79%
FBIOFortress Biotech Inc0.95-291.02%
ORMPOramed Pharmaceuticals Inc1.50-402.53%
AGENAgenus Inc3.01-705.76%
INVAInnoviva Inc3.15-734.83%
VXRTVaxart Inc3.55-814.47%
CRMDCorMedix Inc3.63-830.31%
CVACCureVac N.V.4.45-994.80%
GLPGGalapagos NV4.86-1077.97%
SRPTSarepta Therapeutics Inc4.88-1082.64%
ABEOAbeona Therapeutics Inc5.39-1184.37%
ABUSArbutus Biopharma Corp5.60-1226.26%
ZVRAZevra Therapeutics Inc5.89-1284.95%
SPROSpero Therapeutics Inc6.23-1353.63%
CGENCompugen Ltd6.31-1370.84%
RIGLRigel Pharmaceuticals6.87-1483.18%
SLXNSilexion Therapeutics Corp7.30-1568.52%
OMEROmeros Corporation9.26-1963.56%
AUPHAurinia Pharmaceuticals Inc9.58-2029.21%
PLXProtalix BioTherapeutics Inc10.89-2292.09%
ACADAcadia Pharmaceuticals Inc11.73-2460.66%
TBPHTheravance Biopharma Inc12.26-2568.07%
ADMAAdma Biologics Inc12.42-2599.47%
HRMYHarmony Biosciences Holdings Inc13.82-2881.67%
SABSSAB Biotherapeutics Inc14.14-2945.27%
NAGENiagen Bioscience Inc14.82-3082.53%
INCYIncyte Corp15.82-3284.70%
REGNRegeneron Pharmaceuticals Inc15.86-3291.56%
PBYIPuma Biotechnology Inc17.32-3585.23%
CPRXCatalyst Pharmaceuticals Inc17.44-3610.11%
EXELExelixis Inc17.54-3629.98%
TGTXTG Therapeutics Inc18.97-3917.41%
MDXGMimedx Group Inc20.55-4236.72%
XOMAXOMA Royalty Corp22.87-4704.24%
ARGXArgen X SE24.30-4990.73%
CTMXCytomX Therapeutics Inc24.82-5096.02%
XOMAOXOMA Royalty Corp25.34-5201.43%
HALOHalozyme Therapeutics Inc25.62-5257.57%
XOMAPXOMA Royalty Corp25.67-5266.91%
VRTXVertex Pharmaceuticals Inc27.99-5734.81%
RPRXRoyalty Pharma plc - Class A28.69-5874.26%
SLNOSoleno Therapeutics Inc29.02-5940.24%
ASNDAscendis Pharma A/S30.09-6155.65%
LGNDLigand Pharmaceuticals Inc - Class B37.91-7730.97%
APLSApellis Pharmaceuticals Inc39.02-7954.24%
BMRNBiomarin Pharmaceutical Inc42.21-8596.45%
KRYSKrystal Biotech Inc45.34-9226.79%
ONCBeiGene Ltd69.54-14097.18%
PHARPharming Group N.V.75.03-15201.24%
TECHBio-Techne Corp101.96-20622.31%
VCELVericel Corp109.92-22225.10%
ALNYAlnylam Pharmaceuticals Inc117.96-23844.16%
GMABGenmab140.29-28337.90%
TLXTelix Pharmaceuticals Ltd162.15-32738.33%
CORTCorcept Therapeutics Inc212.86-42944.23%